Introduction: A Drug Class That Redefined an Industry Very few pharmaceutical innovations have managed to simultaneously reshape clinical practice, redefine commercial markets, and establish new benchmarks in intellectual property strategy. GLP-1 receptor

Every week, thousands of patent applications are published across jurisdictions—quietly revealing the next wave of technological advancement. Among these, filings under the Patent Cooperation Treaty (PCT) stand out as a unique signal of global intent. While

For decades, intellectual property systems have operated on a fundamental assumption: innovation is a human endeavor. Patents, copyrights, and other forms of protection have been designed around the idea that inventions originate from human ingenuity and

Artificial intelligence has rapidly entered the world of intellectual property, promising to transform how patents are searched, analyzed, drafted, and even litigated. From automated prior art searches to AI-assisted claim drafting, the narrative is

In the world of patents, finality has always been a cornerstone of certainty. Once a patent is examined, challenged, and upheld, it is expected to provide a degree of stability—allowing innovators to move forward with confidence. But what happens when that

For years, global innovation leadership has been concentrated in a handful of regions—most notably the United States, Europe, and China. Patent filings, often used as a proxy for innovation strength, have historically reflected this distribution. But recent